We are live on
!
Find out more
IIC
Integrated Investment Consultants Portfolio holdings
AUM
$471M
1-Year Est. Return
20.31%
This Fund
S&P 500
This Quarter
Est. Return
+5.51%
1 Year Est. Return
+20.31%
3 Year Est. Return
+59.13%
5 Year Est. Return
+67%
10 Year Est. Return
–
AUM
$316M
AUM Growth
-$2.6M
(-0.82%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
301
New
23
Increased
94
Reduced
87
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.09M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$856K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$740K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$663K |
| 5 |
iShares Morningstar Mid-Cap Growth ETF
IMCG
|
+$500K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$11.3M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$4.42M |
| 3 |
AstraZeneca
AZN
|
+$615K |
| 4 |
Genmab
GMAB
|
+$519K |
| 5 |
ASML
ASML
|
+$474K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.6% |
| 2 | Consumer Discretionary | 6.51% |
| 3 | Financials | 5.85% |
| 4 | Industrials | 4.93% |
| 5 | Healthcare | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Alkermes
ALKS
$8.26B
| – | – |
-9,230
| Closed | -$260K |
|
277
Aptiv
APTV
$10.3B
| – | – |
-2,058
| Closed | -$231K |
|
278
Accuray
ARAY
$33M
| – | – |
-13,500
| Closed | -$40.1K |
|
|
279
AstraZeneca
AZN
$245B
| – | – |
-4,428
| Closed | -$615K |
|
280
Alibaba
BABA
$298B
| – | – |
-3,287
| Closed | -$336K |
|
281
Becton Dickinson
BDX
$48.8B
| – | – |
-839
| Closed | -$208K |
|
282
Check Point Software Technologies
CHKP
$13.1B
| – | – |
-1,990
| Closed | -$259K |
|
|
CMA
283
DELISTED
Comerica
CMA
| – | – |
-6,214
| Closed | -$270K |
|
284
FT Vest US Equity Deep Buffer ETF February
DFEB
$464M
| – | – |
-6,754
| Closed | -$227K |
|
285
Corning
GLW
$144B
| – | – |
-6,733
| Closed | -$238K |
|
|
286
Genmab
GMAB
$19.5B
| – | – |
-13,738
| Closed | -$519K |
|
287
ICICI Bank
IBN
$107B
| – | – |
-14,905
| Closed | -$322K |
|
288
JD.com
JD
$42.1B
| – | – |
-4,699
| Closed | -$206K |
|
289
Grand Canyon Education
LOPE
$3.69B
| – | – |
-1,787
| Closed | -$204K |
|
290
Melco Resorts & Entertainment
MLCO
$2.15B
| – | – |
-33,370
| Closed | -$425K |
|
291
RTX Corp
RTX
$297B
| – | – |
-2,327
| Closed | -$228K |
|
|
SCS
292
DELISTED
Steelcase
SCS
| – | – |
-23,209
| Closed | -$195K |
|
293
Sea Limited
SE
$77.5B
| – | – |
-3,499
| Closed | -$303K |
|
294
Atlassian
TEAM
$38.7B
| – | – |
-1,908
| Closed | -$327K |
|
295
Trane Technologies
TT
$106B
| – | – |
-1,262
| Closed | -$232K |
|
296
UBS Group
UBS
$177B
| – | – |
-12,371
| Closed | -$264K |
|
297
Vale
VALE
$61.5B
| – | – |
-17,058
| Closed | -$269K |
|
298
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.7B
| – | – |
-2,528
| Closed | -$203K |
|
299
Verisk Analytics
VRSK
$23.4B
| – | – |
-1,307
| Closed | -$251K |
|
300
Verizon
VZ
$195B
| – | – |
-5,489
| Closed | -$213K |
|
Similar funds
RCM
SIA
BSI
IC
GBWM
CTWM
CCM
SP
Integrated Investment Consultants's Q2 2023 Portfolio in Review
As of Q2 2023, Integrated Investment Consultants held 301 positions worth $316M, down 0.82% from $318M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Integrated Investment Consultants withdrew a net $16.5M in Q2 2023, closing 28 positions and reducing 87 holdings. Its most notable exit was AstraZeneca, an estimated $615K position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Integrated Investment Consultants opened a new position in Invesco S&P 500 GARP ETF worth $489K.
- Integrated Investment Consultants's largest Q2 2023 buy was Invesco S&P 500 GARP ETF: 5,386 shares worth $489K.
- Integrated Investment Consultants added most to iShares Core MSCI EAFE ETF in Q2 2023, an estimated $1.09M increase.
- Integrated Investment Consultants's biggest Q2 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $11.3M.
- Integrated Investment Consultants fully exited AstraZeneca in Q2 2023, selling an estimated $615K.
- Integrated Investment Consultants's ten largest holdings make up 40% of its $316M portfolio in Q2 2023.
- Integrated Investment Consultants opened 23 new positions and closed 28 in Q2 2023.
- Integrated Investment Consultants's portfolio value fell 0.82% quarter-over-quarter to $316M.
Based on Integrated Investment Consultants's 13F filing for Q2 2023, filed 18 Jul 2023.